
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
Table of Contents
almost 24 years ago
How to Target Top Prescribersalmost 24 years ago
Shake Hands on Rx Drugs for Medicarealmost 24 years ago
Eisai Rises in the Westalmost 24 years ago
Wintertime Stew





